LegacyXChange (LEGX) 10-K 15 Jun 15 2015 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Mar. 31, 2015	Jun. 15, 2015	Sep. 30, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	True 2 Beauty Inc.
Entity Central Index Key	1423579
Amendment Flag	FALSE
Current Fiscal Year End Date	-28
Document Type	10-K
Document Period End Date	31-Mar-15
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2015
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$928,486
Entity Common Stock, Shares Outstanding		38,383,154

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Mar. 31, 2015	Mar. 31, 2014
CURRENT ASSETS:
Cash	$4,362	$9,345
Prepaid expenses	28,801	18,225
Security deposit		636
Total Current Assets	33,163	28,206
TOTAL ASSETS	33,163	28,206
CURRENT LIABILITIES:
Accounts payable and accrued liabilities	113,747	33,575
Accrued officer salary and director fees	8,050	21,250
Advances for common stock purchases		113,525
Due to shareholder		8,218
Due to officer		508
Derivative liabilities	1,088,085
Loans payable		20,000
Deferred revenue		327
Total Current Liabilities	1,209,882	197,403
Convertible notes payable, net of discount	70,087
TOTAL LIABILITIES	1,279,969	197,403
COMMITMENTS (Note 12)
STOCKHOLDERS' DEFICIT:
Preferred stock ($0.001 par value; 10,000,000 shares authorized; No share issued or outstanding at March 31, 2015 and 2014)
Common stock, ($0.001 par value; 190,000,000 shares authorized; 36,951,165 and 31,601,531 shares issued and outstanding at March 31, 2015 and 2014, respectively)	36,951	31,601
Additional paid-in capital	8,332,206	8,042,803
Accumulated deficit	-9,615,963	-8,243,601
TOTAL STOCKHOLDERS' DEFICIT	-1,246,806	-169,197
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$33,163	$28,206

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2015	Mar. 31, 2014
Statement of Financial Position [Abstract]
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	190,000,000	190,000,000
Common stock, shares issued	36,951,165	31,601,531
Common stock, shares outstanding	36,951,165	31,601,531

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Income Statement [Abstract]
REVENUE, NET	$437	$35,240
COST OF REVENUE	2,226	34,168
GROSS (LOSS) PROFIT	-1,789	1,072
OPERATING EXPENSES
Compensation and related taxes	156,873	134,235
Professional fees	361,463	200,797
Other selling, general and administrative	70,862	57,053
TOTAL OPERATING EXPENSES	589,198	392,085
LOSS FROM OPERATIONS	-590,987	-391,013
OTHER INCOME (EXPENSE)
Gain from settlement of accounts payable		34,594
Interest expense	-70,905	-7,510
Initial derivative expense	-35,875
Loss from change in fair value of derivative liabilities	-669,085
Loss on settlement of loans	-5,510
TOTAL OTHER INCOME (EXPENSE)	-781,375	27,084
NET LOSS	($1,372,362)	($363,929)
NET LOSS PER COMMON SHARE
Basic and diluted	($0.04)	($0.01)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING:
Basic and diluted	36,143,636	29,745,802

Consolidated_Statements_of_Cha

Consolidated Statements of Changes in Stockholders' Deficit (USD $)	Total	Preferred Stock	Common Stock	Additional Paid-in Capital	Common Stock Subscription Receivable	Accumulated Deficit
Beginning balance at Mar. 31, 2013	($55,514)		$27,241	$7,806,917	($10,000)	($7,879,672)
Beginning balance, shares at Mar. 31, 2013			27,241,331
Stock issued for services, value	102,761		1,865	100,896
Stock issued for services, shares			1,865,000
Stock issued to settle accounts payable, value	123,975		2,250	121,725
Stock issued to settle accounts payable, shares			2,250,000
Stock sold for cash and receipt of subscriptions receivable, value	18,000		145	7,855	10,000
Stock sold for cash and receipt of subscriptions receivable, shares			145,200
Stock issued for payment for loan fees, value	-5,510		100	5,410
Stock issued for payment for loan fees, shares			100,000
Net loss	-363,929					-363,929
Ending balance at Mar. 31, 2014	-169,197		31,601	8,042,803		-8,243,601
Ending balance, shares at Mar. 31, 2014			31,601,531
Stock issued for services, value	81,823		1,485	80,338
Stock issued for services, shares			1,485,000
Stock issued to settle accounts payable, value
Stock issued for payment for loan fees, value
Net loss	-1,372,362					-1,372,362
Stock sold for cash and advance received in 2014, value	185,420		3,365	182,055
Stock sold for cash and advance received in 2014, shares			3,365,334
Stock issued for loan settlements, value	27,510		500	27,010
Stock issued for loan settlements, shares			499,300
Ending balance at Mar. 31, 2015	($1,246,806)		$36,951	$8,332,206		($9,615,963)
Ending balance, shares at Mar. 31, 2015			36,951,165

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	($1,372,362)	($363,929)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation and fees	78,150	88,986
Stock issued for loan fees		5,510
Gain from settlement of accounts payable		-34,594
Loss on settlement of loans	5,510
Amortization of debt discount	53,212
Initial fair value of derivative liabilities	35,875
Loss from change in fair value of derivative liabilities	669,085
Changes in operating assets and liabilities:
Prepaid expenses	-6,903	34,955
Prepaid salary to officer		26,666
Security deposit	636
Inventories		29,282
Accounts payable and accrued liabilities	82,172	22,400
Deferred revenue	-327	327
Accrued officer salary and director fees	-13,200	20,500
Due to shareholder	-8,218	8,218
Due to officer	-508	-122
Net cash used in operating activities	-476,878	-161,801
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds received from convertible notes	400,000
Proceeds received from loans payable		20,000
Proceeds received as advance for future common stock subscriptions		113,525
Proceeds received from sale of stock	71,895	18,000
Net cash provided by financing activities	471,895	151,525
NET DECREASE IN CASH AND CASH EQUIVALENTS	-4,983	-10,276
CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR	9,345	19,621
CASH AND CASH EQUIVALENTS - END OF YEAR	4,362	9,345
Cash paid for:
Interest
Income taxes
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Stock issued for future services	33,060	82,650
Stock issued for accounts payable		123,975
Stock issued for loans' principal	20,000
Stock issued for accrued interest	2,000
Stock issued for common stock subscription advances	$113,525

Organization_and_Nature_of_Ope

Organization and Nature of Operations	12 Months Ended
	Mar. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND NATURE OF OPERATIONS	NOTE 1 – ORGANIZATION AND NATURE OF OPERATIONS
	True 2 Beauty, Inc. (the “Company”) was originally incorporated as Burrow Mining, Inc., a Nevada corporation, on December 11, 2006. In February 2010, the Company shifted its focus to the beauty industry and later amended its Articles of Incorporation and changed its name to True 2 Beauty, Inc., to better reflect its new business focus.
	On July 10, 2012, the Company formed a new wholly owned subsidiary True2Bid, Inc. (“True2Bid”) which was incorporated in the state of Nevada. This subsidiary’s name was changed to LegacyXChange, Inc. (“LegacyXChange”) in December 2014. The Company continued to sell existing inventory of beauty products through May 2013 when the final inventory was sold. LegacyXChange operates an online e-commerce platform focused on delivering users a wide array of sports and entertainment related products that can be won in an action packed environment of a live auction.

Basis_of_Presentation_Going_Co

Basis of Presentation, Going Concern and Summary of Significant Accounting Policies	12 Months Ended
	Mar. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION, GOING CONCERN AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – BASIS OF PRESENTATION, GOING CONCERN AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Principles of consolidation
	The Company’s consolidated financial statements include the financial statement of its wholly-owned subsidiary, LegacyXChange, Inc. All intercompany accounts and transactions have been eliminated in consolidation.
	Going concern
	These consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates, among other things, the realization of assets and the satisfaction of liabilities in the normal course of business.
	As reflected in the accompanying consolidated financial statements, the Company had a net loss of $1,372,362 and $363,929 for the years ended March 31, 2015 and 2014, respectively, and net cash used in operations of $476,878 and $161,801 for the years ended March 31, 2015 and 2014, respectively, and an accumulated deficit, a stockholders’ deficit and a working capital deficit of $9,615,963, $1,246,806 and $1,176,719, respectively, at March 31, 2015, has a gross loss for the year ended March 31, 2015 and has minimal gross profit for the year ended March 31, 2014. These matters raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company’s ability to raise additional capital, implement its business plan, and generate significant revenues. The consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. The Company plans on raising capital through the sale of equity or debt instruments to implement its business plan. There is no assurance these plans will be realized.
	Use of estimates
	The preparation of the consolidated financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates during the years ended March 31, 2015 and 2014 include the valuation of deferred tax assets, valuation of derivative liabilities and the valuation of stock-based compensation and fees.
	Fair value of financial instruments and fair value measurements
	The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:
	●	Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.
	●	Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.
	●	Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.
	The carrying amounts reported in the consolidated balance sheets for cash, accounts payable and accrued expenses, accrued officer salary and director fees, approximate their fair market value based on the short-term maturity of these instruments.
	Certain financial instruments, such as certain accounts payable, embody obligations that require (or permit at the Company’s discretion) settlement by issuance of a variable number of the Company’s common shares that have a value equal to a fixed monetary amount. The number of shares required to be issued to settle that unconditional obligation is variable, because that number of common shares will be determined by the fair value of the Company’s common shares on the date of settlement or over a stated period of time, such as the average over the last 30 days before settlement, or the beginning of the quarter. Pursuant to ASC 480-10-25-14(a), the financial instruments are classified as a liability at the fixed monetary amount with a charge to expense to increase the obligation to the fixed monetary amount. Upon issuance of the shares to settle the obligation, equity is increased by the amount of the liability and no gain or loss is recognized for the difference between the settlement date or average market price and the ending market price.
	The following table reflects changes for the year ended March 31, 2015 for all financial assets and liabilities categorized as Level 3 as of March 31, 2015.
			Derivative		Fixed Monetary Obligation
			Liabilities
	Liabilities:
	Balance as of March 31, 2014		$	-	$	-
	Initial fair value of derivative liabilities attributable to conversion feature			419,000		-
	Increase in fair value of fixed monetary obligation			-		6,667
	Loss from change in the fair value of derivative liabilities			669,085		-
	Balance as of March 31, 2015		$	1,088,085	$	6,667
	ASC 825-10 “Financial Instruments”, allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding instruments.
	Cash and cash equivalents
	Cash and cash equivalents consist of cash and short-term highly liquid investments purchased with original maturities of three months or less. There were no cash equivalents at March 31, 2015 and 2014.
	Inventories and cost of revenue
	Inventories are stated at the lower of cost or market value. Cost is determined using the cost to acquire inventory and is valued using the first-in, first-out method. Any inventory adjustments are based upon management’s review of inventories on hand compared to estimated future usage and sales. As of March 31, 2015 and 2014, the Company has no inventory on hand because after May 2013 products sold were drop shipped from the Company’s vendors to the Company’s customers.
	Deferred revenue
	Deferred revenue represents revenue collected from the sale of bid packages for the Company’s online auctions but not earned as of the report date. Deferred revenue totaled $0 and $327 at March 31, 2015 and 2014, respectively.
	Advances for common stock purchases
	Advances for common stock purchases consist of prepayments from investors for the purchase of common stock prior to the signing of a stock subscription agreement which was signed after the period end. The Company reclassified to equity the advances for common stock purchases at the time the stock subscription was signed. At March 31, 2015 and 2014, the Company had advances for common stock purchases of $0 and $113,525, respectively.
	Revenue recognition
	The Company recognizes revenue when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the purchase price is fixed or determinable and collectability is reasonably assured. The Company’s specific revenue recognition policies are as follows:
	●	Product sales from the sale of beauty products by the parent entity (which ceased in May 2013) and sales of products through the subsidiary’s auction site are recognized when the product is shipped to the customer and title is transferred.
	●	To participate in the Company’s auction program, consumers are required to purchase bid packages directly from the Company. Proceeds from the sales of bid packages are recorded as deferred revenue until recognizable as discussed below. In connection with the sale of bid packages, the Company utilized the User-based Revenue Model (“UBRM”). The UBRM is based on the presumption that the period of delivery for the bid package is the estimated average user life which was estimated by the Company to be 60 days. Consequently, revenue from the sale of bid packages is recognized ratably over the estimated user life of 60 days.
	Stock-based compensation
	Stock-based compensation is accounted for based on the requirements of the Share-Based Payment Topic of ASC 718 which requires recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). The ASC also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award.
	Pursuant to ASC 505-50, for share-based payments to consultants and other third-parties, compensation expense is determined at the “measurement date.” The expense is recognized over the service period of the award. Until the measurement date is reached, the total amount of compensation expense remains uncertain. The Company initially records compensation expense based on the fair value of the award at the reporting date.
	Income taxes
	Deferred income tax assets and liabilities arise from temporary differences associated with differences between the financial statements and tax basis of assets and liabilities, as measured by the enacted tax rates, which are expected to be in effect when these differences reverse. Deferred tax assets and liabilities are classified as current or non-current, depending upon the classification of the asset or liabilities to which they relate. Deferred tax assets and liabilities not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.
	The Company follows the provisions of FASB ASC 740-10 “Uncertainty in Income Taxes” (ASC 740-10). Certain recognition thresholds must be met before a tax position is recognized in the financial statements. An entity may only recognize or continue to recognize tax positions that meet a “more-likely-than-not” threshold. As of March 31, 2015 and 2014, the Company does not believe it has any uncertain tax positions that would require either recognition or disclosure in the accompanying consolidated financial statements.
	Shipping costs
	Shipping costs are included in other selling, general and administrative expense and totaled $305 and $4,039 for the years ended March 31, 2015 and 2014, respectively.
	Advertising
	Advertising is expensed as incurred and is included in other selling, general and administrative expense. The Company did not incur any advertising expense for the years ended March 31, 2015 and 2014.
	Research and development
	Expenditures for research and product development costs are expensed as incurred. The Company did not incur any research and development expense during the years ended March 31, 2015 and 2014.
	Basic and diluted earnings per share
	Pursuant to ASC 260-10-45, basic earnings (loss) per common share is computed by dividing income (loss) allocable to common shareholders by the weighted average number of shares of common stock outstanding for the periods presented. Diluted income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during each period. Diluted income (loss) per share reflects the potential dilution that could occur if securities were exercised or converted into common stock or other contracts to issue common stock resulting in the issuance of common stock that would then share in the Company’s income (loss) subject to anti-dilution limitations. Potentially dilutive common shares consist of common stock issuable for stock warrants (using the treasury stock method). For the years ended March 31, 2015 and 2014, all potentially dilutive securities are excluded from the computation of diluted weighted average number of shares of common stock outstanding as they would have had an anti-dilutive impact. The Company’s aggregate common stock equivalents at March 31, 2015 and 2014 included the following:
			31-Mar-15		31-Mar-14
	Stock warrants			1,048,315		733,609
	Total			1,048,315		733,609
	Related parties
	Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal with if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The Company discloses all related party transactions. All transactions are recorded at fair value of the goods or services exchanged.
	Recent accounting pronouncements
	In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (ASU 2014-09), which supersedes nearly all existing revenue recognition guidance under U.S. GAAP. The core principle of ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services. ASU 2014-09 defines a five step process to achieve this core principle and, in doing so, more judgment and estimates may be required within the revenue recognition process than are required under existing U.S. GAAP. The standard is effective for annual periods beginning after December 15, 2016, and interim periods therein, using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote disclosures). Early adoption is not permitted. The adoption of this guidance is not expected to have a material impact on the Company’s consolidated financial statements.
	In June 2014, the FASB issued Accounting Standards Update No. 2014-12, Compensation — Stock Compensation (Topic 718), Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period (a consensus of the FASB Emerging Issues Task Force) (ASU 2014-12). The guidance applies to all reporting entities that grant their employees share-based payments in which the terms of the award provide that a performance target that affects vesting could be achieved after the requisite service period. The amendments require that a performance target that affects vesting and that could be achieved after the requisite service period is treated as a performance condition. For all entities, the amendments in this Update are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. Earlier adoption is permitted. The effective date is the same for both public business entities and all other entities. The adoption of this guidance is not expected to have a material impact on the Company’s consolidated financial statements.
	In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Presentation of Financial Statements – Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entities Ability to Continue as a Going Concern (ASU 2014-15). The guidance in ASU 2014-15 sets forth management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern as well as required disclosures. ASU 2014-15 indicates that, when preparing financial statements for interim and annual financial statements, management should evaluate whether conditions or events, in the aggregate, raise substantial doubt about the entity’s ability to continue as a going concern for one year from the date the financial statements are issued or are available to be issued. This evaluation should include consideration of conditions and events that are either known or are reasonably knowable at the date the financial statements are issued or are available to be issued, as well as whether it is probable that management’s plans to address the substantial doubt will be implemented and, if so, whether it is probable that the plans will alleviate the substantial doubt. ASU 2014-15 is effective for annual periods ending after December 15, 2016, and interim periods and annual periods thereafter. Early application is permitted. The adoption of this guidance is not expected to have a material impact on the Company’s consolidated financial statements.

Prepaid_Expenses

Prepaid Expenses	12 Months Ended
	Mar. 31, 2015
Prepaid Expenses [Abstract]
PREPAID EXPENSES	NOTE 3 – PREPAID EXPENSES
	At March 31, 2015 and 2014, prepaid expenses consisted of the following:
		31-Mar-15		31-Mar-14
	Prepaid professional service fees	$	28,801	$	13,775
	Prepaid travel and other expense		-		4,450
		$	28,801	$	18,225

Loans_Payable

Loans Payable	12 Months Ended
	Mar. 31, 2015
Loans and Convertible Notes Payable [Abstract]
LOANS PAYABLE	NOTE 4 – LOANS PAYABLE
	On November 4, 2013, the Company and an individual entered into a loan agreement, providing for the issuance of a loan in the principal amount of $10,000. The loan was due on December 31, 2013. On April 8, 2014, the principal amount of $10,000 and all accrued and unpaid interest of the loan were settled for 249,650 shares of the Company’s common stock, resulting in a loss on settlement of $2,755.
	On November 20, 2013, the Company and an individual entered into a loan agreement, providing for the issuance of a loan in the principal amount of $10,000. The loan was due on December 31, 2013. On April 8, 2014, the principal amount of $10,000 and all accrued and unpaid interest of the loan were settled for 249,650 shares of the Company’s common stock, resulting in a loss on settlement of $2,755.
	At March 31, 2015 and 2014, the total principal for the above loans payable amounted to $0 and $20,000, respectively, which amount was included in loans payable in the accompanying consolidated balance sheets. During the year ended March 31, 2015, the total loss on settlement of the above two loans amounted to $5,510 which was included in loss on settlement of loans in the accompanying consolidated statements of operations (See Note 11). During the year ended March 31, 2014, the total interest expense for the above two loans amounted to $7,510.

Accounts_Payable_and_Accrued_L

Accounts Payable and Accrued Liabilities	12 Months Ended
	Mar. 31, 2015
Accounts Payable And Accrued Liabilities [Abstract]
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES	NOTE 5 – ACCOUNTS PAYABLE AND ACCRUED LIABILITIES
	At March 31, 2015 and 2014, accounts payable and accrued liabilities consisted of the following:
		31-Mar-15		31-Mar-14
	Accrued interest	$	17,693	$	2,000
	Accrued professional fees		67,364		12,922
	Accrued payroll taxes		28,690		18,653
		$	113,747	$	33,575

Accrued_Officer_Salary_and_Dir

Accrued Officer Salary and Director Fees	12 Months Ended
	Mar. 31, 2015
Accrued Officer Salary and Director Fees [Abstract]
ACCRUED OFFICER SALARY AND DIRECTOR FEES	NOTE 6 - ACCRUED OFFICER SALARY AND DIRECTOR FEES
	In connection with the employment of a board of director member, the Company has agreed to compensate him as follows: an initial payment of $1,500 and quarterly payments of $1,500 during the term which he serves as a director of the Company. At March 31, 2015 and 2014, the amount due to this director was $4,750 and $6,750, respectively, and was included in accrued officer salary and director fees in the accompanying consolidated balance sheets.
	At March 31, 2015 and 2014, the accrued and unpaid CEO’s salary was $3,300 and $14,500, respectively, and was included in accrued officer salary and director fees in the accompanying consolidated balance sheets.
	At March 31, 2015 and 2014, accrued officer salary and director fees consisted of the following:
		31-Mar-15		31-Mar-14
	Accrued director's salary	$	4,750	$	6,750
	Accrued officer’s salary		3,300		14,500
		$	8,050	$	21,250

Due_to_Shareholder

Due to Shareholder	12 Months Ended
	Mar. 31, 2015
Stockholders' Equity (Deficit) [Abstract]
Due to shareholder	NOTE 7 – DUE TO SHAREHOLDER
	At March 31, 2015 and 2014, the Company owed one shareholder $0 and $8,218, respectively, for payments made on behalf of the Company and which have been reimbursed by October 2014.

Income_Taxes

Income Taxes	12 Months Ended
	Mar. 31, 2015
Income Taxes [Abstract]
INCOME TAXES	NOTE 8 – INCOME TAXES
	The Company maintains deferred tax assets and liabilities that reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The deferred tax assets at March 31, 2015 and 2014 consist of net operating loss carryforwards. The net deferred tax asset has been fully offset by a valuation allowance because of the uncertainty of the attainment of future taxable income. The items accounting for the difference between income taxes at the effective statutory rate and the provision for income taxes for the years ended March 31, 2015 and 2014 were as follows:
		Years Ended March 31,
		2015			2014
	Income tax expense (benefit) at U.S. statutory rate of 34%	$	(466,603	)	$	(123,736	)
	Income tax benefit  - State		(68,618	)		(18,196	)
	Non-deductible expenses		328,314			52,970
	Change in valuation allowance		206,907			88,962
	Total provision for income tax	$	-		$	-
	The Company’s approximate net deferred tax asset at March 31, 2015 and 2014 was as follows:
	Deferred Tax Asset:	31-Mar-15			31-Mar-14
	Net operating loss carryforward	$	1,047,938		$	841,031
	Valuation allowance		(1,047,938	)		(841,031	)
	Net deferred tax asset	$	-		$	-
	The net operating loss carryforward was $2,687,019 and $2,156,489 at March 31, 2015 and 2014, respectively. The Company provided a valuation allowance equal to the deferred income tax asset for the years ended March 31, 2015 and 2014 because it was not known whether future taxable income will be sufficient to utilize the loss carryforward. The increase in the allowance was $206,907 and $88,962 in fiscal 2015 and fiscal 2014, respectively. The potential tax benefit arising from the loss carryforward will expire in 2035.
	Additionally, the future utilization of the net operating loss carryforward to offset future taxable income may be subject to an annual limitation as a result of ownership changes that could occur in the future. If necessary, the deferred tax assets will be reduced by any carryforward that expires prior to utilization as a result of such limitations, with a corresponding reduction of the valuation allowance.
	The Company does not have any uncertain tax positions or events leading to uncertainty in a tax position. The Company’s 2013, 2014 and 2015 Corporate Income Tax Returns are subject to Internal Revenue Service examination.

Related_Party_Transactions

Related Party Transactions	12 Months Ended
	Mar. 31, 2014
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 9 – RELATED PARTY TRANSACTIONS
	Due to officer
	At March 31, 2015 and 2014, the Company owed Mr. William Bollander, its CEO, $0 and $508, respectively, for payments made on behalf of the Company and which have been reimbursed by March 2015.
	Other
	On October 29, 2014, the Company entered into a service agreement with CFO Oncall Inc., a company majority owned by the Company’s chief financial officer (“CFO Oncall”), effective on November 1, 2014. In accordance to the service agreement, the service fee is $5,000 per month which is payable as follows: $3,000 in cash payable in advance of the 1st of each month, and $2,000 payable at the Company’s option in cash or the Company’s common stock (See Notes 12 and 13).

Convertible_Notes_Payable

Convertible Notes Payable	12 Months Ended
	Mar. 31, 2015
Loans and Convertible Notes Payable [Abstract]
CONVERTIBLE NOTES PAYABLE	NOTE 10 – CONVERTIBLE NOTES PAYABLE
	In October and November 2014, the Company and 7 investors (the “Investors”) entered into convertible promissory note agreements, providing the issuance of a 10% convertible promissory notes (the “Convertible Notes”) with an aggregate principal amount of $400,000. The Convertible Notes are due and payable on the third anniversary of the date of issuance through October 2017. The Investors are entitled, at their option, at any time after the issuance of these Convertible Notes, to convert all or any lesser portion of the outstanding principal amount and accrued but unpaid interest into the Company’s common stock at a conversion price for each share of common stock equal to $0.02. The conversion price of the Convertible Notes shall be subject to adjustment for issuances of common stock at a purchase price of less than the then-effective conversion price. In the event a registration statement is not filed by either the Company within 60 days following the completion of this Offering, or the full amount of Conversion Shares are not included in the first registration statement filed by either entity, or if such registration statement including the Conversion Shares is not declared effective within 180 days following the completion of the Offering, the Convertible Notes shall then be convertible at the option of the Holder into shares of the common stock, par value $.001 per share, of the Company at a conversion price equal to the lesser of $0.02 per share or a 25% discount to the average closing bid price of the Parent Company’s stock for the five days immediately prior to the day upon which the Company receives a written conversion notice from the Holder for any portion of the Notes. The Penalty Conversion shall remain in effect until such time as a registration statement from the Company, including the Conversion Shares is declared effective by the SEC. In connection with the issuance of these Convertible Notes above, the Company determined that the terms of the Convertible Notes include a down-round provision under which the conversion price and exercise price could be affected by future equity offerings undertaken by the Company or contain terms that are not fixed monetary amounts at inception.
	Accordingly, under the provisions of FASB ASC Topic No. 815-40, “Derivatives and Hedging – Contracts in an Entity’s Own Stock”, the embedded conversion option contained in the convertible instruments were accounted for as derivative liabilities at the date of issuance and shall be adjusted to fair value through earnings at each reporting date. The fair value of the embedded conversion option derivatives was determined using the Binomial Option Pricing Model. On the initial measurement date, the fair value of the embedded conversion option derivative of $419,000 was recorded as a derivative liability and was allocated as a debt discount up to the proceeds of the notes ($383,125) with the remainder ($35,875) charged to current period operations as initial derivative expense. Any gains and losses recorded from changes in the fair value of the liability for derivative contract was recorded as a component of other income/(expense) in the accompanying consolidated statements of operations.
	During the year ended March 31, 2015, the fair value of the derivative liabilities were estimated using the Binomial option-pricing model with the following assumptions:
	Dividend rate		0
	Term (in years)		2.5 to 3.0 years
	Volatility		177% to 201%
	Risk-free interest rate		0.83% to 1.10%
	At March 31, 2015, and on the initial measurements of the derivative liabilities, the Company valued the embedded conversion option derivative liabilities resulting in a loss from change in fair value of derivative liabilities of $669,085 for year ended March 31, 2015. For the year ended March 31, 2015, amortization of debt discounts related to these convertible notes amounted to $53,212, which has been included in interest expense on the accompanying consolidated statements of operations.
	At March 31, 2015 and 2014, convertible promissory notes consisted of the following:
		March 31,			March 31,
		2015			2014
	Principal amount	$	400,000		$	-
	Less: unamortized debt discount		(329,913	)		-
	Convertible notes payable, net	$	70,087		$	-

Stockholders_Equity_Deficit

Stockholders' Equity (Deficit)	12 Months Ended
	Mar. 31, 2015
Stockholders' Equity (Deficit) [Abstract]
STOCKHOLDERS' EQUITY (DEFICIT)	NOTE 11 – STOCKHOLDERS’ EQUITY (DEFICIT)
	Authorized shares
	The Company is authorized to issue 10,000,000 shares of its $0.001 par value preferred stock. As of March 31, 2015 and 2014, no shares were issued and outstanding.
	The Company is authorized to issue 190,000,000 shares of its $0.001 par value common stock. As of March 31, 2015 and 2014, 36,951,165 and 31,601,531 shares of common stock were issued and outstanding, respectively.
	Common stock issued for service
	On December 13, 2013, the Company issued 750,000 shares of common stock to a law firm to exchange for the settlement of accounts payable of $75,919 pursuant to a settlement agreement between the Company and the law firm. The shares were valued on the date of grant at their fair value of $41,325 based on the recent sales price of the common stock of $0.0551 per share. In connection with the issuance of these common shares, the Company recognized a gain from settlement of accounts payable of $34,594 which represented the difference between accounts payable at March 31, 2013 of $75,919 for legal fees incurred and the amount of fair value of shares issued of $41,325.
	In June 2013, the Company issued 1,500,000 common shares to settle accounts payable of $82,650. The shares were valued on the date of grant at their fair value of $82,650 based on the recent sales price of the common stock of $0.0551 per share. No gain or loss was recognized on this settlement.
	During the year ended March 31, 2014, the Company issued 1,865,000 shares of common stock for services, including 40,000 shares to the board member, Mr. Christopher Jarvis. The shares were valued on the date of grant at their fair value of $102,761 based on recent sales price of the common stock of $0.0551 per share. The Company recorded stock-based compensation and fees of $88,986, and recorded a remaining prepaid expense of $13,775 at March 31, 2014, which was amortized in fiscal year 2015.
	During the year ended March 31, 2015, the Company issued 1,485,000 shares of common stock for services, including 360,000 shares to a board member of the Company. The shares were valued on the grant date at their fair value of $81,823 based on the recent sales price of the common stock of $0.0551 per share. The Company concluded that the fair value of the equity instruments issued in a share-based payment transaction was a more reliable fair value than the fair value of goods or services received. The Company recorded stock-based compensation and fees of $64,375 and had a remaining prepaid expense of $17,448 at March 31, 2015, which will be amortized over the remaining service periods.
	Common stock sold for cash
	During the fiscal year ended March 31, 2014, the Company sold a total of 145,200 shares of common stock at an average price of $0.0551 per common share to investors. The proceeds received by the Company from the sale of these shares were $8,000 in fiscal 2014.
	During the fiscal year ended March 31, 2015, the Company sold a total of 3,365,334 shares of common stock at an average price of $0.0551 per common share to investors for a total of $185,420. During the year ended March 31, 2015, the Company received cash proceeds of $71,895 from the sale of these shares and decreased advances for common stock purchases of $113,525.
	Common stock issued for payment of loan fees
	During the year ended March 31, 2014, the Company issued a total of 100,000 shares of common stock to two debtors for loan fees. The common shares were valued on the date of grant at their fair value of $5,510 based on recent sales price of the common stock of $0.0551per share. The $5,510 is reflected as interest expense.
	Common stock issued for loan settlements
	During the year ended March 31, 2015, the Company issued a total of 499,300 shares of common stock, valued on the grant date at their fair value of $27,510 based on the recent sales price of the common stock of $0.0551 per share. These shares were issued in settlement of $20,000 in principal and $2,000 of interest, resulting in a loss on settlement of $5,510 which is reflected in Other Expense in the accompanying consolidated statement of operations.
	Warrants
	The Company issued warrants with the sale of common stock during fiscal 2015 and fiscal 2014. The warrants have an exercise price of $0.40 per share and expire in 5 years from issuance date. Warrant activities for the years ended March 31, 2015 and 2014 were as follows:
			Number of Warrants				Weighted Average Exercise Price
	Balance at March 31, 2013			718,608			$	0.4
	Issued			15,001				0.4
	Exercised/forfeited/expired			-				-
	Balance at March 31, 2014			733,609				0.4
	Issued			314,706				0.4
	Exercised/forfeited/expired			-				-
	Balance at March 31, 2015			1,048,315			$	0.4
	Warrant exercisable at March 31, 2015			1,048,315			$	0.4
	There was no intrinsic value of the warrants at March 31, 2015.
	The following table summarizes the shares of the Company’s common stock issuable upon exercise of warrants outstanding at March 31, 2015:
	Warrants Outstanding												Warrants Exercisable
	Range of Exercise Price				Number Outstanding at March 31, 2015				Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Number		Weighted Average Exercise Price
													Exercisable at
													31-Mar-15
	$	0.4				356,250				2.5	$	0.4		356,250	$	0.4
		0.4				25,000				2.6		0.4		25,000		0.4
		0.4				25,500				2.7		0.4		25,500		0.4
		0.4				161,543				2.8		0.4		161,543		0.4
		0.4				103,438				2.9		0.4		103,438		0.4
		0.4				46,877				3		0.4		46,877		0.4
		0.4				15,001				3.1		0.4		15,001		0.4
		0.4				106,912				4.1		0.4		106,912		0.4
		0.4				205,919				4.2		0.4		205,919		0.4
	$	0.4				1,875				4.3		0.4		1,875		0.4
						1,048,315				3.1	$	0.4		1,048,315	$	0.4

Concentrations_and_Commitments

Concentrations and Commitments	12 Months Ended
	Mar. 31, 2015
Concentrations and Commitments [Abstract]
CONCENTRATIONS AND COMMITMENTS	NOTE 12 – CONCENTRATIONS AND COMMITMENTS
	Concentrations
	Concentration of credit risk
	The Company maintains its cash in bank and financial institution deposits that at times may exceed federally insured limits. The Company has not experienced any losses in such accounts through March 31, 2015. There were no balances in excess of FDIC insured levels at March 31, 2015 and 2014.
	Customers
	No customer accounted for 10% or more of the Company’s revenue during the years ended March 31, 2015 and 2014.
	Suppliers
	No supplier accounted for 10% or more of the Company’s purchase during the years ended March 31, 2015 and 2014.
	Commitments
	Service contracts
	In September 2014, the Company signed an eight-month agreement with Applied DNA to work together, in good faith, on a business partnership focused on using Applied DNA Sciences’ unique SigNature© DNA taggant platform, digitalDNA © software platform and other products as required for DNA marking, tracking and authentication of sports collectibles and sports memorabilia uniquely and authentically identified to an athlete (“Goods”) and offered either within a True2Bid online auction exchange environment or through other means of sale. The agreement requires a cash payment of $35,000, of which $10,000 has been paid and the balance of $25,000 shall be paid in two payments of $12,500 each on February 1, 2015 and June 1, 2015. However, there has been no development pursuant to the three phases as defined in the agreement and, accordingly, the Company believes an obligation does not exist and does not intend to pay these installments until the milestones are reached. This agreement expired in May 2015.
	On October 29, 2014, the Company entered into a service agreement with CFO Oncall, effective on November 1, 2014. In accordance to the service agreement, the service fee is $5,000 per month which is payable as follows: $3,000 in cash payable in advance of the 1st of each month, and $2,000 payable at the Company’s option in cash or the Company’s common stock at a 40% discount to quoted market prices. The $2,000 portion is accounted for as stock settled debt in accordance with ASC 480 resulting in a premium on each $2,000 payment amount of $1,333. Accumulated premium included in accounts payable at March 31, 2015 was $6,667 (See Note 13).
	Subsequent commitments
	On May 1, 2015, the Company entered into a one-year legal service agreement with Frederick M. Lehrer, Esquire (“FML”) who has agreed to provide corporate and securities related legal services to the Company. The agreement expires on April 30, 2016. In accordance to this legal service agreement, the Company pays FML (a) a flat cash fee of $1,000 per month; and (b) an annual stock fee of 175,000 shares of the Company’s common stock. The Company issued the 175,000 shares of common stock in June 2015 (See Note 13).
	On May 1, 2015, the Company entered into a one-year consulting agreement with a consultant who has agreed to provide consulting services to the Company. The agreement expires on April 30, 2016. In accordance to this consulting agreement, the Company pays this consultant (a) $6,000 to be paid in equal monthly installments; and (b) 180,000 shares of the Company’s common stock. The Company issued the 180,000 shares of common stock in June 2015 (See Note 13).
	On June 1, 2015, the Company entered into a one-year consulting agreement with a consultant who has agreed to provide consulting services to the Company. The agreement expires on May 31, 2016. In accordance to this consulting agreement, the Company pays the consultant (a) Per Tier 1 athlete/celebrity: (i) 2,500 shares of the Company’s common stock; (ii) 4% of the advertising revenue generated from items offered for sale on the site related to the athlete/celebrity, which were not sold directly by the athlete/celebrity; (iii) 1% of the net item sales of any original merchandise sold by the athlete/celebrity; (b) For all other tiers, including collectible specialists, corporations: (i) 1,500 shares of the Company’s common stock; (ii) 3% of the advertising revenue generated from items offered for sale on the site related to the athlete/celebrity, which were not sold directly by the athlete/celebrity; (iii) 1% of the net item sales of any original merchandise sold by the athlete/celebrity or entity; (c) 250,000 shares of the Company’s common stock upon signing, plus $3,500 per month for the following services: (i) advisory services related to professional sports franchises; (ii) introduction to sports related industry leaders; (iii) assistance in athlete management; (iv) assistance in athlete promotions. For (a) and (b), the percentage of net sales and percentage of advertising revenue will be paid to the consultant as long as the athlete/celebrity/other remains a vendor for the Company, otherwise the consultant earns no commission or fees. The consultant will be paid any commission on the 10th of each month for revenue generated in the preceding month, and the first of every month for the $3,500 monthly payment. The Company issued the 250,000 shares of common stock in June 2015 (See Note 13).

Subsequent_Events

Subsequent Events	12 Months Ended
	Mar. 31, 2015
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 13 – SUBSEQUENT EVENTS
	Common stock issued for service
	On April 27, 2015, the Company issued 100,000 shares of common stock to a consultant for services rendered. The shares were valued at the fair market value on the grant date of $0.06 per share based on market price and the Company recorded stock-based fees $6,000.
	On May 1, 2015, the Company issued 180,000 shares of common stock to a consultant for services to be rendered. The shares were valued at the fair market value on the grant date of $0.0549 per share based on market price and the Company recorded prepaid expense of $9,882, which will be amortized over the service period.
	On May 1, 2015, the Company issued 175,000 shares of common stock to a law firm for services to be rendered. The shares were valued at the fair market value on the grant date of $0.0549 per share based on market price and the Company recorded prepaid expense of $9,608, which will be amortized over the service period.
	On June 1, 2015, the Company issued 726,989 shares of common stock to CFO Oncall to settle accrued liabilities of $26,667 pursuant to the related service agreement between the Company and CFO Oncall (See Note 9 and 12). The shares were valued at $26,667 based on the 60% of the bid price of the Company’s common stock at the last trading day of the previous quarter as defined in the service agreement. No gain or loss was recognized on this settlement.
	On June 1, 2015, the Company issued 250,000 shares of common stock to a consultant for services to be rendered. The shares were valued at the fair market value on the grant date of $0.054 per share based on market price and the Company recorded prepaid expense of $13,500, which will be amortized over the service period.
	Fiscal 2016 Convertible Notes
	On May 19, 2015 and June 1, 2015, the Company and 5 investors (the “Investors”) entered into convertible promissory note agreements, providing the issuance of a 10% convertible promissory notes (the “Fiscal 2016 Convertible Notes”) with an aggregate principal amount of $110,000. The Fiscal 2016 Convertible Notes are due and payable on the third anniversary of the date of May 19, 2018 and June 1, 2018. The Investors are entitled, at their option, at any time after the issuance of these Fiscal 2016 Convertible Notes, to convert all or any lesser portion of the outstanding principal amount and accrued but unpaid interest into the Company’s common stock at a conversion price for each share of common stock equal to $0.05. The conversion price of the Fiscal 2016 Convertible Notes shall be subject to adjustment for issuances of common stock at a purchase price of less than the then-effective conversion price.
	In connection with the issuance of these Fiscal 2016 Convertible Notes, the Company issued five-year common stock purchase warrants (“Warrants”) exercisable at $0.07 per share. These investors received 20 Warrants for each dollar invested in the Fiscal 2016 Convertible Notes. The exercise price of the Warrant shall be subject to adjustment for issuance of common stock at a consideration per share of less than the then-effective exercise price.
	In connection with the issuance of these Fiscal 2016 Convertible Notes, the Company determined that the terms of the Fiscal 2016 Convertible Notes and the 2,200,000 warrants include down-round provisions under which the conversion price and exercise price could be affected by future equity offerings undertaken by the Company or contain terms that are not fixed monetary amounts at inception. Accordingly, under the provisions of FASB ASC Topic No. 815-40, “Derivatives and Hedging – Contracts in an Entity’s Own Stock”, the embedded conversion option contained in the convertible instruments and warrants were accounted for as a derivative liabilities at the date of issuance and shall be adjusted to fair value through earnings at each reporting date. The fair value of the embedded conversion option derivatives and warrants derivatives was determined using the Binomial Option Pricing Model. On the initial measurement date, the fair value of the embedded conversion option derivatives and warrants derivatives of $223,671 was recorded as a derivative liability and was allocated as a debt discount up to the proceeds of the notes ($110,000) with the remainder ($113,671) charged to current period operations as initial derivative expense. Any gains and losses recorded from changes in the fair value of the liability for derivative contract will be recorded as a component of other income/(expense) in the consolidated statements of operations.

Basis_of_Presentation_Going_Co1

Basis of Presentation, Going Concern and Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Mar. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Principles of consolidation	Principles of consolidation
	The Company’s consolidated financial statements include the financial statement of its wholly-owned subsidiary, LegacyXChange, Inc. All intercompany accounts and transactions have been eliminated in consolidation.
Going concern	Going concern
	These consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates, among other things, the realization of assets and the satisfaction of liabilities in the normal course of business.
	As reflected in the accompanying consolidated financial statements, the Company had a net loss of $1,372,362 and $363,929 for the years ended March 31, 2015 and 2014, respectively, and net cash used in operations of $476,878 and $161,801 for the years ended March 31, 2015 and 2014, respectively, and an accumulated deficit, a stockholders’ deficit and a working capital deficit of $9,615,963, $1,246,806 and $1,176,719, respectively, at March 31, 2015, has a gross loss for the year ended March 31, 2015 and has minimal gross profit for the year ended March 31, 2014. These matters raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company’s ability to raise additional capital, implement its business plan, and generate significant revenues. The consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. The Company plans on raising capital through the sale of equity or debt instruments to implement its business plan. There is no assurance these plans will be realized.
Use of estimates	Use of estimates
	The preparation of the consolidated financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates during the years ended March 31, 2015 and 2014 include the valuation of deferred tax assets, valuation of derivative liabilities and the valuation of stock-based compensation and fees.
Fair value of financial instruments and fair value measurements	Fair value of financial instruments and fair value measurements
	The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:
	●	Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.
	●	Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.
	●	Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.
	The carrying amounts reported in the consolidated balance sheets for cash, accounts payable and accrued expenses, accrued officer salary and director fees, approximate their fair market value based on the short-term maturity of these instruments.
	Certain financial instruments, such as certain accounts payable, embody obligations that require (or permit at the Company’s discretion) settlement by issuance of a variable number of the Company’s common shares that have a value equal to a fixed monetary amount. The number of shares required to be issued to settle that unconditional obligation is variable, because that number of common shares will be determined by the fair value of the Company’s common shares on the date of settlement or over a stated period of time, such as the average over the last 30 days before settlement, or the beginning of the quarter. Pursuant to ASC 480-10-25-14(a), the financial instruments are classified as a liability at the fixed monetary amount with a charge to expense to increase the obligation to the fixed monetary amount. Upon issuance of the shares to settle the obligation, equity is increased by the amount of the liability and no gain or loss is recognized for the difference between the settlement date or average market price and the ending market price.
	The following table reflects changes for the year ended March 31, 2015 for all financial assets and liabilities categorized as Level 3 as of March 31, 2015.
			Derivative		Fixed Monetary Obligation
			Liabilities
	Liabilities:
	Balance as of March 31, 2014		$	-	$	-
	Initial fair value of derivative liabilities attributable to conversion feature			419,000		-
	Increase in fair value of fixed monetary obligation			-		6,667
	Loss from change in the fair value of derivative liabilities			669,085		-
	Balance as of March 31, 2015		$	1,088,085	$	6,667
	ASC 825-10 “Financial Instruments”, allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding instruments.
Cash and cash equivalents	Cash and cash equivalents
	Cash and cash equivalents consist of cash and short-term highly liquid investments purchased with original maturities of three months or less. There were no cash equivalents at March 31, 2015 and 2014.
Inventories and cost of revenue	Inventories and cost of revenue
	Inventories are stated at the lower of cost or market value. Cost is determined using the cost to acquire inventory and is valued using the first-in, first-out method. Any inventory adjustments are based upon management’s review of inventories on hand compared to estimated future usage and sales. As of March 31, 2015 and 2014, the Company has no inventory on hand because after May 2013 products sold were drop shipped from the Company’s vendors to the Company’s customers.
Deferred revenue	Deferred revenue
	Deferred revenue represents revenue collected from the sale of bid packages for the Company’s online auctions but not earned as of the report date. Deferred revenue totaled $0 and $327 at March 31, 2015 and 2014, respectively.
Advances for common stock purchases	Advances for common stock purchases
	Advances for common stock purchases consist of prepayments from investors for the purchase of common stock prior to the signing of a stock subscription agreement which was signed after the period end. The Company reclassified to equity the advances for common stock purchases at the time the stock subscription was signed. At March 31, 2015 and 2014, the Company had advances for common stock purchases of $0 and $113,525, respectively.
Revenue recognition	Revenue recognition
	The Company recognizes revenue when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the purchase price is fixed or determinable and collectability is reasonably assured. The Company’s specific revenue recognition policies are as follows:
	●	Product sales from the sale of beauty products by the parent entity (which ceased in May 2013) and sales of products through the subsidiary’s auction site are recognized when the product is shipped to the customer and title is transferred.
	●	To participate in the Company’s auction program, consumers are required to purchase bid packages directly from the Company. Proceeds from the sales of bid packages are recorded as deferred revenue until recognizable as discussed below. In connection with the sale of bid packages, the Company utilized the User-based Revenue Model (“UBRM”). The UBRM is based on the presumption that the period of delivery for the bid package is the estimated average user life which was estimated by the Company to be 60 days. Consequently, revenue from the sale of bid packages is recognized ratably over the estimated user life of 60 days.
Stock-based compensation	Stock-based compensation
	Stock-based compensation is accounted for based on the requirements of the Share-Based Payment Topic of ASC 718 which requires recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). The ASC also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award.
	Pursuant to ASC 505-50, for share-based payments to consultants and other third-parties, compensation expense is determined at the “measurement date.” The expense is recognized over the service period of the award. Until the measurement date is reached, the total amount of compensation expense remains uncertain. The Company initially records compensation expense based on the fair value of the award at the reporting date.
Income taxes	Income taxes
	Deferred income tax assets and liabilities arise from temporary differences associated with differences between the financial statements and tax basis of assets and liabilities, as measured by the enacted tax rates, which are expected to be in effect when these differences reverse. Deferred tax assets and liabilities are classified as current or non-current, depending upon the classification of the asset or liabilities to which they relate. Deferred tax assets and liabilities not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.
	The Company follows the provisions of FASB ASC 740-10 “Uncertainty in Income Taxes” (ASC 740-10). Certain recognition thresholds must be met before a tax position is recognized in the financial statements. An entity may only recognize or continue to recognize tax positions that meet a “more-likely-than-not” threshold. As of March 31, 2015 and 2014, the Company does not believe it has any uncertain tax positions that would require either recognition or disclosure in the accompanying consolidated financial statements.
Shipping costs	Shipping costs
	Shipping costs are included in other selling, general and administrative expense and totaled $305 and $4,039 for the years ended March 31, 2015 and 2014, respectively.
Advertising	Advertising
	Advertising is expensed as incurred and is included in other selling, general and administrative expense. The Company did not incur any advertising expense for the years ended March 31, 2015 and 2014.
Research and development	Research and development
	Expenditures for research and product development costs are expensed as incurred. The Company did not incur any research and development expense during the years ended March 31, 2015 and 2014.
Basic and diluted earnings per share	Basic and diluted earnings per share
	Pursuant to ASC 260-10-45, basic earnings (loss) per common share is computed by dividing income (loss) allocable to common shareholders by the weighted average number of shares of common stock outstanding for the periods presented. Diluted income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during each period. Diluted income (loss) per share reflects the potential dilution that could occur if securities were exercised or converted into common stock or other contracts to issue common stock resulting in the issuance of common stock that would then share in the Company’s income (loss) subject to anti-dilution limitations. Potentially dilutive common shares consist of common stock issuable for stock warrants (using the treasury stock method). For the years ended March 31, 2015 and 2014, all potentially dilutive securities are excluded from the computation of diluted weighted average number of shares of common stock outstanding as they would have had an anti-dilutive impact. The Company’s aggregate common stock equivalents at March 31, 2015 and 2014 included the following:
			31-Mar-15		31-Mar-14
	Stock warrants			1,048,315		733,609
	Total			1,048,315		733,609
Related parties	Related parties
	Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal with if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The Company discloses all related party transactions. All transactions are recorded at fair value of the goods or services exchanged.
Recent accounting pronouncements	Recent accounting pronouncements
	In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (ASU 2014-09), which supersedes nearly all existing revenue recognition guidance under U.S. GAAP. The core principle of ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services. ASU 2014-09 defines a five step process to achieve this core principle and, in doing so, more judgment and estimates may be required within the revenue recognition process than are required under existing U.S. GAAP. The standard is effective for annual periods beginning after December 15, 2016, and interim periods therein, using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote disclosures). Early adoption is not permitted. The adoption of this guidance is not expected to have a material impact on the Company’s consolidated financial statements.
	In June 2014, the FASB issued Accounting Standards Update No. 2014-12, Compensation — Stock Compensation (Topic 718), Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period (a consensus of the FASB Emerging Issues Task Force) (ASU 2014-12). The guidance applies to all reporting entities that grant their employees share-based payments in which the terms of the award provide that a performance target that affects vesting could be achieved after the requisite service period. The amendments require that a performance target that affects vesting and that could be achieved after the requisite service period is treated as a performance condition. For all entities, the amendments in this Update are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. Earlier adoption is permitted. The effective date is the same for both public business entities and all other entities. The adoption of this guidance is not expected to have a material impact on the Company’s consolidated financial statements.
	In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Presentation of Financial Statements – Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entities Ability to Continue as a Going Concern (ASU 2014-15). The guidance in ASU 2014-15 sets forth management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern as well as required disclosures. ASU 2014-15 indicates that, when preparing financial statements for interim and annual financial statements, management should evaluate whether conditions or events, in the aggregate, raise substantial doubt about the entity’s ability to continue as a going concern for one year from the date the financial statements are issued or are available to be issued. This evaluation should include consideration of conditions and events that are either known or are reasonably knowable at the date the financial statements are issued or are available to be issued, as well as whether it is probable that management’s plans to address the substantial doubt will be implemented and, if so, whether it is probable that the plans will alleviate the substantial doubt. ASU 2014-15 is effective for annual periods ending after December 15, 2016, and interim periods and annual periods thereafter. Early application is permitted. The adoption of this guidance is not expected to have a material impact on the Company’s consolidated financial statements.

Basis_of_Presentation_Going_Co2

Basis of Presentation, Going Concern and Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Mar. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of financial assets and liabilities categorized as Level 3		Derivative		Fixed Monetary Obligation
		Liabilities
	Liabilities:
	Balance as of March 31, 2014	$	-	$	-
	Initial fair value of derivative liabilities attributable to conversion feature		419,000		-
	Increase in fair value of fixed monetary obligation		-		6,667
	Loss from change in the fair value of derivative liabilities		669,085		-
	Balance as of March 31, 2015	$	1,088,085	$	6,667
Schedule of aggregate common stock equivalents		31-Mar-15		31-Mar-14
	Stock warrants		1,048,315		733,609
	Total		1,048,315		733,609

Prepaid_Expenses_Tables

Prepaid Expenses (Tables)	12 Months Ended
	Mar. 31, 2015
Prepaid Expenses [Abstract]
Schedule of prepaid expenses		31-Mar-15		31-Mar-14
	Prepaid professional service fees	$	28,801	$	13,775
	Prepaid travel and other expense		-		4,450
		$	28,801	$	18,225

Accounts_Payable_and_Accrued_L1

Accounts Payable and Accrued Liabilities (Tables)	12 Months Ended
	Mar. 31, 2015
Accounts Payable And Accrued Liabilities [Abstract]
Schedule of accounts payable and accrued liabilities		31-Mar-15		31-Mar-14
	Accrued interest	$	17,693	$	2,000
	Accrued professional fees		67,364		12,922
	Accrued payroll taxes		28,690		18,653
		$	113,747	$	33,575

Accrued_Officer_Salary_and_Dir1

Accrued Officer Salary and Director Fees (Table)	12 Months Ended
	Mar. 31, 2015
Accrued Officer Salary and Director Fees [Abstract]
Schedule of accrued officer salary and director fees		31-Mar-15		31-Mar-14
	Accrued director's salary	$	4,750	$	6,750
	Accrued officer’s salary		3,300		14,500
		$	8,050	$	21,250

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Mar. 31, 2015
Income Taxes [Abstract]
Schedule of effective income tax rate reconciliation		Years Ended March 31,
		2015			2014
	Income tax expense (benefit) at U.S. statutory rate of 34%	$	(466,603	)	$	(123,736	)
	Income tax benefit  - State		(68,618	)		(18,196	)
	Non-deductible expenses		328,314			52,970
	Change in valuation allowance		206,907			88,962
	Total provision for income tax	$	-		$	-
Schedule of net deferred tax asset
	Deferred Tax Asset:	31-Mar-15			31-Mar-14
	Net operating loss carryforward	$	1,047,938		$	841,031
	Valuation allowance		(1,047,938	)		(841,031	)
	Net deferred tax asset	$	-		$	-

Convertible_Notes_Payable_Tabl

Convertible Notes Payable (Tables)	12 Months Ended
	Mar. 31, 2015
Loans and Convertible Notes Payable [Abstract]
Schedule of fair value of the derivative liabilities	Dividend rate		0
	Term (in years)		2.5 to 3.0 years
	Volatility		177% to 201%
	Risk-free interest rate		0.83% to 1.10%
Schedule of convertible promissory notes		March 31,			March 31,
		2015			2014
	Principal amount	$	400,000		$	-
	Less: unamortized debt discount		(329,913	)		-
	Convertible notes payable, net	$	70,087		$	-

Stockholders_Equity_Deficit_Ta

Stockholders' Equity (Deficit) (Tables)	12 Months Ended
	Mar. 31, 2015
Stockholders' Equity (Deficit) [Abstract]
Summary of warrant activities			Number of Warrants				Weighted Average Exercise Price
	Balance at March 31, 2013			718,608			$	0.4
	Issued			15,001				0.4
	Exercised/forfeited/expired			-				-
	Balance at March 31, 2014			733,609				0.4
	Issued			314,706				0.4
	Exercised/forfeited/expired			-				-
	Balance at March 31, 2015			1,048,315			$	0.4
	Warrant exercisable at March 31, 2015			1,048,315			$	0.4
Summary of warrants outstanding	Warrants Outstanding												Warrants Exercisable
	Range of Exercise Price				Number Outstanding at March 31, 2015				Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Number		Weighted Average Exercise Price
													Exercisable at
													31-Mar-15
	$	0.4				356,250				2.5	$	0.4		356,250	$	0.4
		0.4				25,000				2.6		0.4		25,000		0.4
		0.4				25,500				2.7		0.4		25,500		0.4
		0.4				161,543				2.8		0.4		161,543		0.4
		0.4				103,438				2.9		0.4		103,438		0.4
		0.4				46,877				3		0.4		46,877		0.4
		0.4				15,001				3.1		0.4		15,001		0.4
		0.4				106,912				4.1		0.4		106,912		0.4
		0.4				205,919				4.2		0.4		205,919		0.4
	$	0.4				1,875				4.3		0.4		1,875		0.4
						1,048,315				3.1	$	0.4		1,048,315	$	0.4

Basis_of_Presentation_Going_Co3

Basis of Presentation, Going Concern and Summary of Significant Accounting Policies (Details) (USD $)	12 Months Ended
	Mar. 31, 2015
Liabilities:
Balance as of March 31, 2014
Initial fair value of derivative liabilities attributable to conversion feature	419,000
Loss from change in the fair value of derivative liabilities	669,085
Balance as of March 31, 2015	1,088,085
Balance as of March 31, 2014
Increase in fair value of fixed monetary obligation	6,667
Balance as of March 31, 2015	$6,667

Basis_of_Presentation_Going_Co4

Basis of Presentation, Going Concern and Summary of Significant Accounting Policies (Details 1)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total stock warrants	1,048,315	733,609
Stock warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total stock warrants	1,048,315	733,609

Basis_of_Presentation_Going_Co5

Basis of Presentation, Going Concern and Summary of Significant Accounting Policies (Details Textual) (USD $)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2013
Basis of Presentation Going Concern and Summary of Significant Accounting Policies (Textual)
Net loss	($1,372,362)	($363,929)
Net cash used in operating activities	-476,878	-161,801
Accumulated deficit	-9,615,963	-8,243,601
Stockholders deficit	-1,246,806	-169,197	-55,514
Working capital deficit	1,176,719
Deferred revenue	0	327
Advances for common stock purchases	0	113,525
Shipping costs	305	4,039
Advertising expenses
Research and development expense

Prepaid_Expenses_Details

Prepaid Expenses (Details) (USD $)	Mar. 31, 2015	Mar. 31, 2014
Prepaid Expenses [Abstract]
Prepaid professional service fees	$28,801	$13,775
Prepaid travel and other expense		4,450
Total prepaid expenses	$28,801	$18,225

Loans_Payable_Details

Loans Payable (Details) (USD $)	12 Months Ended		0 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Nov. 04, 2013	Apr. 08, 2014	Nov. 20, 2013
Short-term Debt [Line Items]
Loans payable		$20,000
Loan maturity date	31-Oct-17
Loss on settlement of loan payable	-5,510
Interest expense	70,905	7,510
Loan Agreement One [Member]
Short-term Debt [Line Items]
Loans payable			10,000
Loan maturity date			31-Dec-13
Loan conversion amount	10,000
Common stock issued for debt conversion	249,650
Loss on settlement of loan payable	2,755
Loan Agreement Two [Member]
Short-term Debt [Line Items]
Loans payable					10,000
Loan maturity date					31-Dec-13
Loan conversion amount				10,000
Common stock issued for debt conversion				249,650
Loss on settlement of loan payable				$2,755

Accounts_Payable_and_Accrued_L2

Accounts Payable and Accrued Liabilities (Details) (USD $)	Mar. 31, 2015	Mar. 31, 2014
Accounts Payable And Accrued Liabilities [Abstract]
Accrued interest	$17,693	$2,000
Accrued professional fees	67,364	12,922
Accrued payroll taxes	28,690	18,653
Accounts payable and accrued liabilities, Total	$113,747	$33,575

Accrued_Officer_Salary_and_Dir2

Accrued Officer Salary and Director Fees (Details) (USD $)	Mar. 31, 2015	Mar. 31, 2014
Related Party Transaction [Line Items]
Accrued officer salary and director fees	$8,050	$21,250
Director [Member]
Related Party Transaction [Line Items]
Accrued officer salary and director fees	4,750	6,750
Officer [Member]
Related Party Transaction [Line Items]
Accrued officer salary and director fees	$3,300	$14,500

Accrued_Officer_Salary_and_Dir3

Accrued Officer Salary and Director Fees (Detail Textual) (USD $)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Accrued Officer Salary and Director Fees (Textual)
Initial Payment	$1,500
Quarterly Payments	1,500
Accrued Salaries	8,050	21,250
Director [Member]
Accrued Officer Salary and Director Fees (Textual)
Accrued Salaries	4,750	6,750
Officer [Member]
Accrued Officer Salary and Director Fees (Textual)
Accrued Salaries	$3,300	$14,500

Due_to_Shareholder_Details

Due to Shareholder (Details) (USD $)	Mar. 31, 2015	Mar. 31, 2014
Due to Shareholder (Textual)
Payments made on behalf of the company		$8,218

Income_Taxes_Details

Income Taxes (Details) (USD $)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Income Taxes [Abstract]
Income tax expense (benefit) at U.S. statutory rate of 34%	($466,603)	($123,736)
Income tax benefit - State	-68,618	-18,196
Non-deductible expenses	328,314	52,970
Change in valuation allowance	206,907	88,962
Total provision for income tax

Income_Taxes_Details_1

Income Taxes (Details 1) (USD $)	Mar. 31, 2015	Mar. 31, 2014
Deferred Tax Assets, Net [Abstract]
Net operating loss carryforward	$1,047,938	$841,031
Valuation allowance	-1,047,938	-841,031
Net deferred tax asset

Income_Taxes_Details_Textual

Income Taxes (Details Textual) (USD $)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Income Taxes [Abstract]
Net operating loss carryforward	$2,687,019	$2,156,489
Operating loss carryforwards, valuation allowance	$206,907	$88,962
Loss carryforward expire date	31-Dec-35

Related_Party_Transactions_Det

Related Party Transactions (Details) (USD $)	0 Months Ended	1 Months Ended
	Oct. 29, 2014	Oct. 29, 2014	Mar. 31, 2015	Mar. 31, 2014
Related Party Transactions (Textual)
Due to officer				$508
Chief Financial Officer [Member]
Related Party Transactions (Textual)
Servicing Fees	5,000
Cash paid in advance		3,000
Amount paid in cash or common stock		$2,000

Convertible_Notes_Payable_Deta

Convertible Notes Payable (Details)	12 Months Ended
	Mar. 31, 2015
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Dividend rate	0.00%
Maximum [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Term (in years)	3 years
Volatility	201.00%
Risk-free interest rate	1.10%
Minimum [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Term (in years)	2 years 6 months
Volatility	177.00%
Risk-free interest rate	0.83%

Convertible_Notes_Payable_Deta1

Convertible Notes Payable (Details 1) (USD $)	Mar. 31, 2015	Mar. 31, 2014
Loans and Convertible Notes Payable [Abstract]
Principal amount	$400,000
Less: unamortized debt discount	-329,913
Convertible notes payable, net	$70,087

Convertible_Notes_Payable_Deta2

Convertible Notes Payable (Detail Textual) (USD $)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
	Investors
Short-term Debt [Line Items]
Principal amount of debt	$400,000
Number of Investors	7
Convertible note interest rate	10.00%
Convertible note maturity date	31-Oct-17
Conversion share price	$0.02
Convertible note, description	In the event a registration statement is not filed by either the Company within 60 days following the completion of this Offering, or the full amount of Conversion Shares are not included in the first registration statement filed by either entity, or if such registration statement including the Conversion Shares is not declared effective within 180 days following the completion of the Offering, the Convertible Notes shall then be convertible at the option of the Holder into shares of the common stock, par value $.001 per share, of the Company at a conversion price equal to the lesser of $0.02 per share or a 25% discount to the average closing bid price of the Parent Company's stock for the five days immediately prior to the day upon which the Company receives a written conversion notice from the Holder for any portion of the Notes.
Initial fair value of derivative liabilities attributable to conversion feature	419,000
Debt Instrument, discount	329,913
Initial derivative expense	35,875
Fair value of derivative liabilities	669,085
Amortization of debt discount	53,212
Convertible Debt [Member]
Short-term Debt [Line Items]
Debt Instrument, discount	$383,125

Stockholders_Equity_Deficit_De

Stockholders' Equity (Deficit) (Details) (USD $)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Apr. 03, 2014
Stockholders' Equity (Deficit) [Abstract]
Beginning balance	733,609	718,608
Issued	314,706	15,001
Exercised/forfeited/expired
Ending balance	1,048,315	733,609
Warrant exercisable at March 31, 2015	1,048,315
Weighted average exercise price, Beginning balance	$0.40	$0.40	$0.40
Weighted average exercise price, Issued	$0.40	$0.40
Weighted average exercise price, Exercised/ forfeited/ expired
Weighted average exercise price, Ending balance	$0.40	$0.40	$0.40
Weighted average exercise price, Exercisable	$0.40

Stockholders_Equity_Deficit_De1

Stockholders' Equity (Deficit) (Details 1) (Warrant [Member], USD $)	12 Months Ended
	Mar. 31, 2015
Warrants Outstanding And Exercisable [Abstract]
Warrants Outstanding, Number Outstanding at March 31, 2014	1,048,315
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	3 years 1 month 6 days
Warrants Outstanding, Weighted Average Exercise Price	$0.40
Warrants Exercisable, Number Exercisable at March 31, 2014	1,048,315
Warrants Exercisable, Weighted Average Exercise Price	$0.40
0.40 (Member)
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$0.40
Warrants Outstanding, Number Outstanding at March 31, 2014	356,250
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	2 years 6 months
Warrants Outstanding, Weighted Average Exercise Price	$0.40
Warrants Exercisable, Number Exercisable at March 31, 2014	356,250
Warrants Exercisable, Weighted Average Exercise Price	$0.40
0.40 One(Member)
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$0.40
Warrants Outstanding, Number Outstanding at March 31, 2014	25,000
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	2 years 7 months 6 days
Warrants Outstanding, Weighted Average Exercise Price	$0.40
Warrants Exercisable, Number Exercisable at March 31, 2014	25,000
Warrants Exercisable, Weighted Average Exercise Price	$0.40
0.40 Two(Member)
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$0.40
Warrants Outstanding, Number Outstanding at March 31, 2014	25,500
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	2 years 8 months 12 days
Warrants Outstanding, Weighted Average Exercise Price	$0.40
Warrants Exercisable, Number Exercisable at March 31, 2014	25,500
Warrants Exercisable, Weighted Average Exercise Price	$0.40
0.40 Three(Member)
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$0.40
Warrants Outstanding, Number Outstanding at March 31, 2014	161,543
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	2 years 9 months 18 days
Warrants Outstanding, Weighted Average Exercise Price	$0.40
Warrants Exercisable, Number Exercisable at March 31, 2014	161,543
Warrants Exercisable, Weighted Average Exercise Price	$0.40
0.40 Four(Member)
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$0.40
Warrants Outstanding, Number Outstanding at March 31, 2014	103,438
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	2 years 10 months 24 days
Warrants Outstanding, Weighted Average Exercise Price	$0.40
Warrants Exercisable, Number Exercisable at March 31, 2014	103,438
Warrants Exercisable, Weighted Average Exercise Price	$0.40
0.40 Five(Member)
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$0.40
Warrants Outstanding, Number Outstanding at March 31, 2014	46,877
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	3 years
Warrants Outstanding, Weighted Average Exercise Price	$0.40
Warrants Exercisable, Number Exercisable at March 31, 2014	46,877
Warrants Exercisable, Weighted Average Exercise Price	$0.40
0.40 Six(Member)
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$0.40
Warrants Outstanding, Number Outstanding at March 31, 2014	15,001
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	3 years 1 month 6 days
Warrants Outstanding, Weighted Average Exercise Price	$0.40
Warrants Exercisable, Number Exercisable at March 31, 2014	15,001
Warrants Exercisable, Weighted Average Exercise Price	$0.40
0.40 Seven (Member)
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$0.40
Warrants Outstanding, Number Outstanding at March 31, 2014	106,912
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	4 years 1 month 6 days
Warrants Outstanding, Weighted Average Exercise Price	$0.40
Warrants Exercisable, Number Exercisable at March 31, 2014	106,912
Warrants Exercisable, Weighted Average Exercise Price	$0.40
0.40 Eight (Member)
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$0.40
Warrants Outstanding, Number Outstanding at March 31, 2014	205,919
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	4 years 2 months 12 days
Warrants Outstanding, Weighted Average Exercise Price	$0.40
Warrants Exercisable, Number Exercisable at March 31, 2014	205,919
Warrants Exercisable, Weighted Average Exercise Price	$0.40
0.40 Nine (Member)
Warrants Outstanding And Exercisable [Abstract]
Range of Exercise Price	$0.40
Warrants Outstanding, Number Outstanding at March 31, 2014	1,875
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	4 years 3 months 18 days
Warrants Outstanding, Weighted Average Exercise Price	$0.40
Warrants Exercisable, Number Exercisable at March 31, 2014	1,875
Warrants Exercisable, Weighted Average Exercise Price	$0.40

Stockholders_Equity_Deficit_De2

Stockholders' Equity (Deficit) (Details Textual) (USD $)	12 Months Ended			0 Months Ended	1 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2013	Dec. 13, 2013	Jun. 30, 2013
Stockholders (Deficit) Equity (Textual)
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, shares authorized	190,000,000	190,000,000
Common stock, par value	$0.00	$0.00
Common stock, shares issued	36,951,165	31,601,531
Common stock, shares outstanding	36,951,165	31,601,531
Fair value of shares issued	$27,510	$5,510
Gain from settlement of accounts payable		34,594	34,594
Legal fees			75,919
Stock issued for services, value	81,823	102,761
Stock-based compensation and fees	78,150	88,986
Prepaid expense remaining amount	17,448	13,775
Proceeds from issuance of common stock		113,525
Advances for common stock purchases		113,525
Stock issued for payment for loan fees, value		-5,510
Warrants exercise price	$0.40	$0.40
Term of warrants	5 years	5 years
Loss on settlement of loans	5,510
Stock issued principal amount	20,000
Stock issued interest amount	2,000
Investor [Member]
Stockholders (Deficit) Equity (Textual)
common stock price per share	$0.06	$0.06
Issuance of common stock	3,365,334	145,200
Issuance of common stock, Value	185,420
Proceeds from issuance of common stock	71,895	8,000
Mr. Christopher Jarvis
Stockholders (Deficit) Equity (Textual)
Stock issued for services, shares	360,000	40,000
Common Stock [Member]
Stockholders (Deficit) Equity (Textual)
Stock issued to settle accounts payable, value				75,919	82,650
Stock issued to settle accounts payable, shares				750,000	1,500,000
Fair value of shares issued	81,823	102,761		41,325	82,650
common stock price per share	$0.06	$0.06		$0.06	$0.06
Stock issued for services, value	1,485	1,865
Stock issued for services, shares	1,485,000	1,865,000
Stock issued for payment for loan fees, value		$100
Stock issued for payment for loan fees, shares		100,000

Concentrations_and_Commitments1

Concentrations and Commitments (Details) (USD $)	12 Months Ended		0 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Jun. 01, 2015	1-May-15	Oct. 29, 2014	Sep. 30, 2014	Feb. 01, 2015	Jul. 31, 2014
Concentrations and Commitments [Textual]
Prepaid consulting fees	$17,448	$13,775
Common stock, shares issued	36,951,165	31,601,531
Common stock, par value	$0.00	$0.00
Stock-based compensation	78,150	88,986
Cash payment		25,000
Installments of cash paid		10,000
Sep-14
Concentrations and Commitments [Textual]
Cash payment						35,000
Installments of cash paid						25,000
Subsequent Event [Member]
Concentrations and Commitments [Textual]
Common stock, shares issued								250,000
Installments of cash paid							12,500
Subsequent Event [Member] | June 1, 2015
Concentrations and Commitments [Textual]
Common stock, shares issued			250,000
Commitments, Description			(a) Per Tier 1 athlete/celebrity: (i) 2,500 shares of the Company's common stock; (ii) 4% of the advertising revenue generated from items offered for sale on the site related to the athlete/celebrity, which were not sold directly by the athlete/celebrity; (iii) 1% of the net item sales of any original merchandise sold by the athlete/celebrity; (b) For all other tiers, including collectible specialists, corporations: (i) 1,500 shares of the Company's common stock; (ii) 3% of the advertising revenue generated from items offered for sale on the site related to the athlete/celebrity, which were not sold directly by the athlete/celebrity; (iii) 1% of the net item sales of any original merchandise sold by the athlete/celebrity or entity; (c) 250,000 shares of the Company's common stock upon signing, plus $3,500 per month for the following services: (i) advisory services related to professional sports franchises; (ii) introduction to sports related industry leaders; (iii) assistance in athlete management; (iv) assistance in athlete promotions. For (a) and (b), the percentage of net sales and percentage of advertising revenue will be paid to the consultant as long as the athlete/celebrity/other remains a vendor for the Company, otherwise the consultant earns no commission or fees. The consultant will be paid any commission on the 10th of each month for revenue generated in the preceding month, and the first of every month for the $3,500 monthly payment.
Installments of cash paid			3,500
Agreement expired			The agreement expires on May 31, 2016
Subsequent Event [Member] | May 1, 2015
Concentrations and Commitments [Textual]
Common stock, shares issued				180,000
Commitments, Description				(a) $6,000 to be paid in equal monthly installments; and (b) 180,000 shares of the Company's common stock.
Installments of cash paid				6,000
Agreement expired				The agreement expires on April 30, 2016.
Frederick M. Lehrer [Member] | Subsequent Event [Member]
Concentrations and Commitments [Textual]
Common stock, shares issued				175,000
Commitments, Description				(a) a flat cash fee of $1,000 per month; and (b) an annual stock fee of 175,000 shares of the Company's common stock. The Company issued the 175,000 shares of common stock in June 2015 (See Note 13).
Installments of cash paid				1,000
Agreement expired				The agreement expires on April 30, 2016.
CFO Oncall Inc [Member]
Concentrations and Commitments [Textual]
Cash payment					3,000
Service fees					5,000
Percentage of quoted market prices					40.00%
Installments of cash paid					2,000
Stock settled debt					2,000
Premium payment amount					1,333
Accumulated premium included in accounts payable					$6,667

Subsequent_Events_DetailsTextu

Subsequent Events (DetailsTextual) (USD $)	12 Months Ended		0 Months Ended			1 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Jun. 01, 2015	19-May-15	1-May-15	Apr. 27, 2015
	Investors		Investors	Investors
Subsequent Event [Line Items]
Fair value of common share granted	$81,823	$102,761
Number of Investors	7
Principal amount of debt	400,000
Convertible note maturity date	31-Oct-17
Conversion share price	$0.02
Interest expense	70,905	7,510
Warrant exercisable conversion price	1,048,315
Debt Instrument, discount	329,913
Subsequent Event [Member] | Fiscal 2016 Convertible Notes [Member]
Subsequent Event [Line Items]
Number of Investors			5	5
Convertible debt percentage			10.00%	10.00%
Convertible note maturity date			1-Jun-18	19-May-18
Conversion share price			$0.05
Warrant exercisable price			$0.07
Convertible warrants discription			Investors received 20 Warrants for each dollar invested in the Fiscal 2016 Convertible Notes.
Warrant exercisable conversion price			2,200,000
Derivative liability			223,671
Debt Instrument, discount			-110,000
Proceeds from notes payable			-113,671
Subsequent Event [Member] | Consultant [Member]
Subsequent Event [Line Items]
Stock issued for services, shares			250,000		180,000	100,000
Fair market value price per share			$0.05		$0.05	$0.06
Fair value of common share granted			13,500		9,882	6,000
Subsequent Event [Member] | CFO Oncall [Member]
Subsequent Event [Line Items]
Stock issued for services, shares			726,989
Fair value of common share granted			26,667
Trading days description			The shares were valued at $26,667 based on the 60% of the bid price of the Company's common stock at the last trading day of the previous quarter as defined in the service agreement.
Subsequent Event [Member] | Law Firm [Member]
Subsequent Event [Line Items]
Stock issued for services, shares					175,000
Fair market value price per share					$0.05
Fair value of common share granted					$9,608